Release of heparan sulfate from endothelial cells. Implications for pathogenesis of hyperacute rejection
about
Loss of ATP diphosphohydrolase activity with endothelial cell activationHeparan Sulfate Proteoglycan Metabolism and the Fate of Grafted TissuesKidney xenotransplantationXenotransplantation.The modulation of tissue factor by endothelial cells during heat shock.Disordered regulation of coagulation and platelet activation in xenotransplantation.Protective effects of recombinant human antithrombin III in pig-to-primate renal xenotransplantation.Hemolytic uremic syndrome: a fatal outcome after kidney and liver transplantation performed to correct factor h gene mutation.Complement-mediated injury and protection of endothelium: lessons from atypical haemolytic uraemic syndromeSTEC-HUS, atypical HUS and TTP are all diseases of complement activation.Effects of TLR agonists on the hypoxia-regulated transcription factor HIF-1alpha and dendritic cell maturation under normoxic conditionsFactors in xenograft rejection.Thromboregulatory manifestations in human CD39 transgenic mice and the implications for thrombotic disease and transplantation.Role of complement in xenotransplantation.Xenotransplantation--2000Current status of animal-to-human transplantation.Reconstituted high-density lipoprotein modulates activation of human leukocytes.Protease Activity and the Role of the Endothelial Glycocalyx in Inflammation.Shedding of the endothelial glycocalyx in arterioles, capillaries, and venules and its effect on capillary hemodynamics during inflammation.On the intersections of basic and applied research in xenotransplantation.Immunoglobulin prevents complement-mediated hyperacute rejection in swine-to-primate xenotransplantation.Transient perturbation of endothelial integrity induced by natural antibodies and complementComplement-mediated regulation of tissue factor activity in endothelium.Endothelial cell protection in xenotransplantation: looking after a key player in rejection.Decreased fibrinolytic activity in porcine-to-primate cardiac xenotransplantationHuman leukocytes regulate ganglioside expression in cultured micro-pig aortic endothelial cells.Human leukocyte antigen antibody incompatible renal transplantationThe interface between coagulation and immunity.Which anti-platelet therapies might be beneficial in xenotransplantation?The spectrum of antibody-mediated renal allograft injury: implications for treatment.Modulation of eicosanoid metabolism in endothelial cells in a xenograft model. Role of cyclooxygenase-2.Role of complement and perspectives for intervention in ischemia-reperfusion damage.The endothelial glycocalyx as a barrier to leukocyte adhesion and its mediation by extracellular proteases.Trauma alarmins as activators of damage-induced inflammation.The role of platelets in coagulation dysfunction in xenotransplantation, and therapeutic options.Current status of pig kidney xenotransplantationThe pathobiology of pig-to-primate xenotransplantation: a historical review.Beneficial effect of a nitric oxide donor in an ex vivo model of pig-to-human pulmonary xenotransplantation.Role of vascular endothelial cells in the allograft response.A perspective on xenograft rejection and accommodation.
P2860
Q24670257-51BE3C99-C1A3-45D4-8F05-6AF32BBEBD00Q26797410-7573B814-B311-4BC2-82EE-5252039A1363Q26822638-F06EF2B3-85F3-4812-A14D-D83CA3B496C7Q30838629-D73993C1-926C-4807-ACEA-A490FD9E96F3Q30882582-4DE400FE-02A7-4A4C-893C-0564C024F1C4Q33334538-3BEB3532-40EC-4E2B-9286-4E4FB9639A0CQ33343240-1D898E4D-B257-4B10-B479-E58CE23757FFQ33365746-B79A0C1E-1C80-4FFC-ACF8-217B1D3F4276Q33396792-4E98DC4C-503C-4703-8EC9-C07C406C45FBQ33403359-59B2AD5B-061E-4160-B4A9-E9A3CBC3B11AQ33601510-6F09F36D-756B-417D-A968-3A331B47528FQ33692579-78FEAEF3-8C78-4805-84EF-A229B3FFB0C4Q33784839-AC1415E0-C53C-49C3-B6BE-2EC4EE7F826AQ33811443-ECF4154D-EC52-419E-9261-64F6C187F65CQ33893048-B9FCC30C-34A1-4D3E-BD5D-B687C88FECDAQ34665240-7049FFDC-9029-4E65-8DD9-0517C1C61C9DQ34963571-0418FFAC-6010-48F3-AD87-FEC8C3252DD5Q35503145-F182DF51-B3A4-4479-91BA-CBA8F363999DQ35601382-42E7C69A-2B95-4662-9804-2E2A1210A73AQ35687758-710622BD-3369-451F-B7B2-3DA4F261DFC5Q35766497-CCA2F4A7-7A53-424A-A914-ECC4A8E8E449Q36364261-08498F8E-D998-4D2A-87FA-7B333B5F3068Q36365648-4CF6C343-D423-44C4-98C1-D9DDC4A52638Q36404498-90524739-6C66-4007-BF6E-EB93A431B844Q36438240-55707A89-C1B9-4082-B0D4-77B5698864A9Q36524500-34D35699-E66E-42E0-B3ED-09A6B06F88FDQ36612789-18282E41-680E-4E91-BF98-D4C85D213FB5Q36710224-B46CF94B-AC6F-4A24-A5A8-AB9B88A9CB15Q37069089-BED4EB6A-C4E4-45EE-BED2-5BC90BC0DF74Q37176570-9A81B81A-1475-4257-9BFE-576CC21D939FQ37371806-A8660C8F-E7EF-4FA8-BABD-CE7CC37E7996Q37831329-9C4AEAE7-7DA4-4034-926B-DBE62255DE17Q37943787-CCF500AF-0B8A-457B-9221-D67DD25166B1Q37996337-37AB00E5-53F1-419A-8980-DEEAE517FC5DQ38191251-C604D4D2-39FF-412E-AD55-F57CAD641977Q38573513-57AB2A30-9F95-4CDE-B488-8CECE7B683B4Q38712532-8E0F8969-EC3F-4E40-A893-157F3B7E03ABQ38834627-14922777-974D-4C7C-9CD6-A45825FE29DAQ40412720-A5973A6F-0852-4425-AB0F-8BD863A3C5DEQ40600276-4A6EE806-155C-46F4-AE66-EC67748F45D9
P2860
Release of heparan sulfate from endothelial cells. Implications for pathogenesis of hyperacute rejection
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年学术文章
@wuu
1990年学术文章
@zh-cn
1990年学术文章
@zh-hans
1990年学术文章
@zh-my
1990年学术文章
@zh-sg
1990年學術文章
@yue
1990年學術文章
@zh
1990年學術文章
@zh-hant
name
Release of heparan sulfate fro ...... enesis of hyperacute rejection
@ast
Release of heparan sulfate fro ...... enesis of hyperacute rejection
@en
type
label
Release of heparan sulfate fro ...... enesis of hyperacute rejection
@ast
Release of heparan sulfate fro ...... enesis of hyperacute rejection
@en
prefLabel
Release of heparan sulfate fro ...... enesis of hyperacute rejection
@ast
Release of heparan sulfate fro ...... enesis of hyperacute rejection
@en
P2093
P2860
P356
P1476
Release of heparan sulfate fro ...... enesis of hyperacute rejection
@en
P2093
A P Dalmasso
B J Lindman
G M Vercellotti
T R Oegema
P2860
P304
P356
10.1084/JEM.171.4.1363
P407
P577
1990-04-01T00:00:00Z